Carroll Financial Associates’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-19,431
| Closed | -$39K | – | 1338 |
|
|
2018
Q3 | $39K | Hold |
19,431
| – | – | ﹤0.01% | 554 |
|
|
2018
Q2 | $35K | Hold |
19,431
| – | – | ﹤0.01% | 557 |
|
|
2018
Q1 | $45K | Buy |
+19,431
| New | +$45K | ﹤0.01% | 509 |
|
|
2017
Q4 | – | Sell |
-19,431
| Closed | -$47K | – | 1264 |
|
|
2017
Q3 | $47K | Hold |
19,431
| – | – | 0.01% | 502 |
|
|
2017
Q2 | $53K | Hold |
19,431
| – | – | 0.01% | 483 |
|
|
2017
Q1 | $58K | Hold |
19,431
| – | – | 0.01% | 448 |
|
|
2016
Q4 | $61K | Hold |
19,431
| – | – | 0.01% | 427 |
|
|
2016
Q3 | $66K | Hold |
19,431
| – | – | 0.01% | 419 |
|
|
2016
Q2 | $44K | Hold |
19,431
| – | – | 0.01% | 466 |
|
|
2016
Q1 | $48K | Sell |
19,431
-1,632
| -8% | -$4.03K | 0.01% | 434 |
|
|
2015
Q4 | $69K | Hold |
21,063
| – | – | 0.01% | 348 |
|
|
2015
Q3 | $63K | Hold |
21,063
| – | – | 0.01% | 352 |
|
|
2015
Q2 | $62K | Buy |
+21,063
| New | +$62K | 0.01% | 336 |
|